🇺🇸 FDA
Patent

US 8071084

Vaccine for protection against Shigella sonnei disease

granted A61KA61K2039/522A61K39/0283

Quick answer

US patent 8071084 (Vaccine for protection against Shigella sonnei disease) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/522, A61K39/0283, A61P, A61P31/04